Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuria

Journal of Diabetes and its Complications

Volumn 30, Issue 2, 2016, Pages 248-255

  Von Scholten, Bernt Johan ^a   Reinhard, Henrik ^a   Hansen, Tine Willum ^a   Schalkwijk, Casper G ^b   Stehouwer, Coen ^b   Parving, Hans Henrik ^c,d   Jacobsen, Peter Karl ^d   Rossing, Peter ^a,d,e  

^a STENO DIABETES CENTER   (Denmark)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

Author keywords

Cardiovascular disease; Coronary artery calcium score; Markers of inflammation; Microalbuminuria; TNF alpha; Type 2 diabetes

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 1BETA; INTERLEUKIN 8; PADGEM PROTEIN; SERUM AMYLOID A; SOLUBLE ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; SOLUBLE INTERCELLULAR ADHESION MOLECULE 1; SOLUBLE INTERCELLULAR ADHESION MOLECULE 3; SOLUBLE P SELECTIN; SOLUBLE VASCULAR CELL ADHESION MOLECULE 1; THROMBOMODULIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE HEART INFARCTION; ADULT; AGE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CALCIUM SCORE; CORONARY ARTERY DISEASE; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART FAILURE; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SMOKING; AGED; ALBUMINURIA; BLOOD; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COMPLICATION; CORONARY DISEASE; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DISEASE COURSE; INFLAMMATION; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR CALCIFICATION; VASCULAR ENDOTHELIUM;

AGED; ALBUMINURIA; BIOMARKERS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INCIDENCE; INFLAMMATION; MALE; MIDDLE AGED; VASCULAR CALCIFICATION;

EID: 84949309603     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2015.11.005     Document Type: Article

References (33)

1. A.I. Adler, R.J. Stevens, S.E. Manley, R.W. Bilous, C.A. Cull, and R.R. Holman Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64) Kidney International 63 2003 225 232
2. A.S. Agatston, W.R. Janowitz, F.J. Hildner, N.R. Zusmer, M. Viamonte Jr., and R. Detrano Quantification of coronary artery calcium using ultrafast computed tomography Journal of the American College of Cardiology 15 1990 827 832
3. V. Borcea, M. Morcos, B. Isermann, M. Henkels, S. Ziegler, and M. Zumbach P.P. Nawroth Influence of ramipril on the course of plasma thrombomodulin in patients with diabetes mellitus VASA 28 1999 172 180
4. M.J. Budoff, J.E. Hokanson, K. Nasir, L.J. Shaw, G.L. Kinney, and D. Chow P. Raggi Progression of coronary artery calcium predicts all-cause mortality JACC. Cardiovascular Imaging 3 2010 1229 1236
5. B.S. Cain, D.R. Meldrum, C.A. Dinarello, X. Meng, K.S. Joo, and A. Banerjee A.H. Harken Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function Critical Care Medicine 27 1999 1309 1318
6. F. Califano, T. Giovanniello, P. Pantone, E. Campana, C. Parlapiano, and F. Alegiani P. Turchetti Clinical importance of thrombomodulin serum levels European Review for Medical and Pharmacological Sciences 4 2000 59 66
7. J. Channual, J.J. Wu, and F.J. Dann Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis Dermatologic Therapy 22 2009 61 73
8. A.T. Cheung, D. Ree, J.K. Kolls, J. Fuselier, D.H. Coy, and M. Bryer-Ash An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: Evidence for differential regulation of insulin signaling by TNF-alpha Endocrinology 139 1998 4928 4935
9. A.Y. Chong, A.D. Blann, and G.Y. Lip Assessment of endothelial damage and dysfunction: observations in relation to heart failure QJM 96 2003 253 267
10. J. de Jager, J.M. Dekker, A. Kooy, P.J. Kostense, G. Nijpels, and R.J. Heine C.D. Stehouwer Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: The Hoorn Study Arteriosclerosis, Thrombosis, and Vascular Biology 26 2006 1086 1093
11. J. de Jager, A. Kooy, C. Schalkwijk, J. van der Kolk, P. Lehert, and D. Bets C.D. Stehouwer Long-term effects of metformin on endothelial function in type 2 diabetes: A randomized controlled trial Journal of Internal Medicine 275 2014 59 70
12. N. Esser, N. Paquot, and A.J. Scheen Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease Expert Opinion on Investigational Drugs 24 2015 283 307
13. B.M. Everett, A.D. Pradhan, D.H. Solomon, N. Paynter, J. Macfadyen, and E. Zaharris P.M. Ridker Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis American Heart Journal 166 2013 199 207
14. S. Gabat, C. Keller, H.P. Kempe, J. Amiral, R. Ziegler, and E. Ritz P. Nawroth Plasma thrombomodulin: A marker for microvascular complications in diabetes mellitus VASA 25 1996 233 241
15. P. Gaede, P. Vedel, N. Larsen, G.V. Jensen, H.H. Parving, and O. Pedersen Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes The New England Journal of Medicine 348 2003 383 393
16. J.P. Garg, and G.L. Bakris Microalbuminuria: Marker of vascular dysfunction, risk factor for cardiovascular disease Vascular Medicine 7 2002 35 43
17. M.A. Gonzalez-Gay, C. Gonzalez-Juanatey, T.R. Vazquez-Rodriguez, J.A. Miranda-Filloy, and J. Llorca Insulin resistance in rheumatoid arthritis: The impact of the anti-TNF-alpha therapy Annals of the New York Academy of Sciences 1193 2010 153 159
18. S.M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction The New England Journal of Medicine 339 1998 229 234
19. J.E. Hokanson, T. MacKenzie, G. Kinney, J.K. Snell-Bergeon, D. Dabelea, and J. Ehrlich M. Rewers Evaluating changes in coronary artery calcium: An analytic method that accounts for interscan variability AJR. American Journal of Roentgenology 182 2004 1327 1332
20. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
21. A.J. Littler, C.D. Buckley, P. Wordsworth, I. Collins, J. Martinson, and D.L. Simmons A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis British Journal of Rheumatology 36 1997 164 169
22. S. Martin, P. Rieckmann, I. Melchers, R. Wagner, J. Bertrams, and A.E. Voskuyl H. Kolb Circulating forms of ICAM-3 (cICAM-3). Elevated levels in autoimmune diseases and lack of association with cICAM-1 Journal of Immunology 154 1995 1951 1955
23. J.F. Navarro-Gonzalez, and C. Mora-Fernandez The role of inflammatory cytokines in diabetic nephropathy Journal of the American Society of Nephrology 19 2008 433 442
24. E. Parmentier-Decrucq, A. Duhamel, O. Ernst, C. Fermont, A. Louvet, and G. Vernier-Massouille L. Peyrin-Biroulet Effects of infliximab therapy on abdominal fat and metabolic profile in patients with Crohn's disease Inflammatory Bowel Diseases 15 2009 1476 1484
25. D.J. Rader IL-1 and atherosclerosis: A murine twist to an evolving human story The Journal of Clinical Investigation 122 2012 27 30
26. H. Reinhard, P.R. Hansen, F. Persson, L. Tarnow, N. Wiinberg, and A. Kjær P.K. Jacobsen Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate Nephrology, Dialysis, Transplantation 26 2011 3242 3249
27. P.M. Ridker, T. Thuren, A. Zalewski, and P. Libby Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) American Heart Journal 162 2011 597 605
28. M. Seigneur, P. Dufourcq, C. Conri, J. Constans, P. Mercié, and A. Pruvost M.R. Boisseau Levels of plasma thrombomodulin are increased in atheromatous arterial disease Thrombosis Research 71 1993 423 431
29. X. Shi, Y. Chen, L. Nadeem, and G. Xu Beneficial effect of TNF-α inhibition on diabetic peripheral neuropathy Journal of Neuroinflammation 10 2013 69
30. C.D. Stehouwer, M.A. Gall, J.W. Twisk, E. Knudsen, J.J. Emeis, and H.H. Parving Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: Progressive, interrelated, and independently associated with risk of death Diabetes 51 2002 1157 1165
31. L. Tarnow, M.A. Gall, B.V. Hansen, P. Hovind, and H.H. Parving Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes Diabetologia 49 2006 2256 2262
32. T.T. van Sloten, R.M. Henry, J.M. Dekker, G. Nijpels, T. Unger, and M.T. Schram C.D. Stehouwer Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: The Hoorn study Hypertension 64 2014 1299 1305
33. B.J. von Scholten, H. Reinhard, T.W. Hansen, M. Lindhardt, C.L. Petersen, and N. Wiinberg P. Rossing Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes Cardiovascular Diabetology 14 2015 59 10.1186/s12933-015-0225-0